These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8300052)

  • 1. Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance.
    Clemmons DR
    Horm Res; 1993; 40(1-3):62-7. PubMed ID: 8300052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR; Smith-Banks A; Underwood LE
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
    Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and insulin-like growth factor-I counteracts established steroid catabolism in rats by effects on hepatic amino-N degradation.
    Grøfte T; Jensen DS; Greisen J; Tygstrup N; Vilstrup H
    J Hepatol; 2001 Dec; 35(6):700-6. PubMed ID: 11738095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.
    Mauras N; Haymond MW
    Pediatr Nephrol; 1996 Jun; 10(3):318-23. PubMed ID: 8792396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
    Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER
    J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in nutritional status].
    Chevenne D; Porquet D
    Ann Biol Clin (Paris); 1995; 53(10-11):527-38. PubMed ID: 8787278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats.
    Thissen JP; Triest S; Underwood LE; Maes M; Ketelslegers JM
    Endocrinology; 1990 Feb; 126(2):908-13. PubMed ID: 2298175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
    Berneis K; Ninnis R; Girard J; Frey BM; Keller U
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2528-34. PubMed ID: 9253329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin-like growth factor I and/or growth hormone on diaphragm of malnourished adolescent rats.
    Lewis MI; LoRusso TJ; Fournier M
    J Appl Physiol (1985); 1997 Apr; 82(4):1064-70. PubMed ID: 9104840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans.
    Oehri M; Ninnis R; Girard J; Frey FJ; Keller U
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E552-8. PubMed ID: 8928758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
    Lieberman SA; Butterfield GE; Harrison D; Hoffman AR
    J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.